Endogenous prolactin-releasing peptide regulates food intake in rodents by Takayanagi, Y. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Endogenous prolactin-releasing peptide regulates food intake in
rodents
Citation for published version:
Takayanagi, Y, Matsumoto, H, Nakata, M, Mera, T, Fukusumi, S, Hinuma, S, Ueta, Y, Yada, T, Leng, G &
Onaka, T 2008, 'Endogenous prolactin-releasing peptide regulates food intake in rodents' Journal of Clinical
Investigation, vol. 118, no. 12, pp. 4014-4024. DOI: 10.1172/JCI34682
Digital Object Identifier (DOI):
10.1172/JCI34682
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Clinical Investigation
Publisher Rights Statement:
Free access article.
Users of the online version of the Journal of Clinical Investigation (JCI) (the publication of the American Society
for Clinical Investigation, or ASCI), may view, reproduce, or store copies of the journal providing the information
is only for their individual use. Use of the online version of the JCI constitutes an agreement to comply with this
and the following terms. Any copies, in whole or in part, must include the copyright notice.
http://www.jci.org/kiosk/terms
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Research article
4014	 The	Journal	of	Clinical	Investigation	 	 	 http://www.jci.org	 	 	 Volume 118	 	 	 Number 12	 	 	 December 2008
Endogenous prolactin-releasing peptide 
regulates food intake in rodents
Yuki Takayanagi,1 Hirokazu Matsumoto,2 Masanori Nakata,3 Takashi Mera,4 Shoji Fukusumi,5  
Shuji Hinuma,5 Yoichi Ueta,4 Toshihiko Yada,3 Gareth Leng,6 and Tatsushi Onaka1
1Division of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Tochigi, Japan.  
2Frontier Research Laboratories I, Pharmaceutical Research Division, Takeda Chemical Industries Ltd., Tsukuba, Ibaraki, Japan.  
3Division of Integrative Physiology, Department of Physiology, Jichi Medical University, Shimotsuke, Tochigi, Japan.  
4Department of Physiology, University of Occupational and Environmental Health, Kitakyushu, Japan.  
5Research Information & Alliances Strategic Research Planning Department, Pharmaceutical Research Division, Takeda Chemical Industries Ltd.,  
Juso-honmachi, Yodogawaku, Osaka, Japan. 6Centre for Integrative Physiology, School of Biomedical Sciences,  
University of Edinburgh, Edinburgh, United Kingdom.
Food	intake	is	regulated	by	a	network	of	signals	that	emanate	from	the	gut	and	the	brainstem.	The	peripheral	
satiety	signal	cholecystokinin	is	released	from	the	gut	following	food	intake	and	acts	on	fibers	of	the	vagus	
nerve,	which	project	to	the	brainstem	and	activate	neurons	that	modulate	both	gastrointestinal	function	and	
appetite.	In	this	study,	we	found	that	neurons	in	the	nucleus	tractus	solitarii	of	the	brainstem	that	express	
prolactin-releasing	peptide	(PrRP)	are	activated	rapidly	by	food	ingestion.	To	further	examine	the	role	of	this	
peptide	in	the	control	of	food	intake	and	energy	metabolism,	we	generated	PrRP-deficient	mice	and	found	that	
they	displayed	late-onset	obesity	and	adiposity,	phenotypes	that	reflected	an	increase	in	meal	size,	hyperphagia,	
and	attenuated	responses	to	the	anorexigenic	signals	cholecystokinin	and	leptin.	Hypothalamic	expression	of	
6	other	appetite-regulating	peptides	remained	unchanged	in	the	PrRP-deficient	mice.	Blockade	of	endogenous	
PrRP	signaling	in	WT	rats	by	central	injection	of	PrRP-specific	mAb	resulted	in	an	increase	in	food	intake,	as	
reflected	by	an	increase	in	meal	size.	These	data	suggest	that	PrRP	relays	satiety	signals	within	the	brain	and	
that	selective	disturbance	of	this	system	can	result	in	obesity	and	associated	metabolic	disorders.
Introduction
Classically, feeding is regulated by an alternation between hunger 
and satiety signals, which include both circulating factors and 
neurally mediated signals from the gastrointestinal tract (1). These 
signals act on the peripheral organs and on the CNS, including 
the hypothalamus and brainstem, to initiate or terminate food 
intake. One important satiety signal is the brain-gut peptide cho-
lecystokinin (CCK). CCK, released from the gut in response to a 
meal, has an important regulatory role in gastrointestinal func-
tion, inhibiting gastric motility and emptying via a neural reflex 
within the caudal brainstem or via a reflex loop that ascends to the 
hypothalamus via a relay in the caudal brainstem (2, 3), but is also 
involved in the regulation of food intake. Peripheral CCK acts on 
afferent nerve fibers of the gastric vagus nerve; these vagal neurons 
project to the caudal brainstem (4), where they activate neurons 
that project to hypothalamic nuclei involved in appetite regulation 
(2, 3). In particular, peripheral injections of CCK activate neurons 
in the nucleus tractus solitarii (NTS) and ventrolateral medulla, 
including specific subpopulations of the noradrenergic neurons of 
the A1 and A2 cell groups (5). These noradrenergic neurons com-
prise several subpopulations, which are anatomically, biochemi-
cally, and functionally separate.
Some of these noradrenergic neurons express prolactin-releasing 
peptide (PrRP; encoded by the Prlh gene) (6). PrRP was discovered 
as an endogenous ligand for the GPCR GPR10 (encoded by the 
Prlhr gene) (7), and PrRP-expressing neurons are localized in the 
NTS and ventrolateral medulla oblongata and in the dorsomedial 
hypothalamus (8, 9). In the medulla oblongata, PrRP is exclusively 
colocalized in noradrenergic neurons (6). PrRP has been suggested 
to be involved in energy metabolism (10–15), stress responses 
(16–19), and analgesia (20).
Peripheral administration of CCK activates neurons expressing 
PrRP (11). There have also been several other indications that PrRP 
might be involved in the regulation of feeding and energy balance. 
In particular, central administration of PrRP reduces food intake 
in rats (10), and PrRP mRNA expression decreases during fasting 
and is low during lactation, a physiological state of negative energy 
balance (10). Mice that lack the PrRP receptor GPR10 show adult-
onset obesity (15, 21) and, most interestingly, do not reduce their 
feeding in response to CCK (22).
Here, we examined the role of endogenous PrRP in the control 
of food intake and energy metabolism by studies in Tg mice defi-
cient in PrRP and by neutralizing the actions of endogenous PrRP 
in mice and rats using mAb specific for PrRP. We also investigated 
whether food intake activates PrRP neurons in the caudal brain-
stem. In this study, we demonstrate that in rodents, PrRP relays 
satiety signals within the brain and that perturbation of this system 
can predispose to obesity and associated metabolic disorders.
Results
Generation of PrRP-deficient mice. To generate mice deficient in PrRP, 
we designed a targeting vector to disrupt exons 1 and 2 including 
full coding regions of the prepro-PrRP sequence (Figure 1A). Male 
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pose tissue; CART, cocaine- and amphetamine-regulated transcript; CCK, cholecys-
tokinin; CRH, corticotrophin-releasing hormone; i.c.v., intracerebroventricular(ly); 
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response element–binding protein; POMC, proopiomelanocortin; PrRP, prolactin-
releasing peptide; UCP1, uncoupling protein 1; VO2, oxygen consumption.
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chimeric mice transmitted the mutant Prlh allele to their offspring. 
The heterozygous mice were apparently normal and were inter-
crossed to obtain homozygous offspring; these mice were viable 
(Figure 1B). PrRP transcripts and proteins were not detectable in 
PrRP-deficient mice, confirming the disruption of the Prlh gene 
(Figure 1, C and D).
Adult-onset obesity in PrRP-deficient mice. When WT, PrRP-hetero-
zygous, and PrRP-deficient mice from heterozygous intercrosses 
were fed a high-fat diet ad libitum from the age of 5 weeks, PrRP-
deficient mice became significantly heavier than either WT mice 
or PrRP-heterozygous mice by the age of 7 weeks (Figure 2A). 
When maintained on standard laboratory chow, PrRP-deficient 
mice weighed significantly more than WT mice at 18 weeks of 
age (Figure 2B), which was apparently attributable to greater food 
consumption (Figure 2C). PrRP-deficient mice had substantially 
more body fat than WT mice (Figure 2D), and this was accom-
panied by reduced glucose tolerance and increased insulin resis-
tance (Figure 2, E and F). Both WAT mass, in either subcutaneous 
pads or intraabdominal pads (perirenal, mesenteric, epididymal), 
and brown adipose tissue (BAT) mass were greater in PrRP-defi-
cient mice than in WT mice (Figure 2G), and epididymal adipo-
cytes of PrRP-deficient mice were larger than those in WT mice 
(Figure 2H). The hepatic tissue of PrRP-deficient mice contained 
many large fatty vesicles, indicating fatty liver (Figure 2H). Plasma 
concentrations of insulin, leptin, and triglyceride were higher in 
PrRP-deficient than in WT mice (insulin: WT, 850 ± 191 pg/ml, 
PrRP-deficient, 3,001 ± 672 pg/ml; leptin: WT, 11.5 ± 5.9 ng/ml, 
PrRP-deficient, 40.3 ± 12.9 ng/ml; triglyceride: WT, 71.2 ± 3.5 ng/dl, 
PrRP-deficient, 95.5 ± 5.7 ng/dl). Hepatic triglyceride concentra-
tions were also higher in PrRP-deficient mice than in WT mice 
(1.23 ± 0.25 vs. 0.27 ± 0.04 mg/mg protein). The greater BW gain 
of PrRP-deficient mice was more prominent when they were fed 
a high-fat diet (Figure 3A), and this was associated with a signifi-
cantly greater food intake (Figure 3B).
Energy expenditure in PrRP-deficient mice. To examine the patho-
genesis of obesity in PrRP-deficient mice, amounts of food sup-
plied were restricted to the mean food intake of age-matched WT 
mice. Under these conditions, the BWs of pair-fed PrRP-deficient 
mice did not differ significantly from those of WT mice (Fig-
ure 3C). Glucose tolerance and insulin resistance were also not 
significantly different in WT and pair-fed PrRP-deficient mice 
(Figure 3, D and E).
We found no significant differences between WT and PrRP-defi-
cient mice in locomotor activity in their home cages (Figure 4A) 
Figure 1
Generation of PrRP-deficient mice. (A) Genomic structure of the murine Prlh gene and the targeting vector; and predicted genomic structure 
of the targeted allele. Exons (E1, E2) are indicated by black boxes. Positions of restriction enzyme sites and the probes used for Southern 
blot analysis are shown. E, EcoRI; V, VspI; B, BamHI; H, HpaI; X, XhoI; neo, neomycin phosphotransferase resistance cassette. (B) Southern 
blot analysis of tail genomic DNA isolated from WT, PrRP-heterozygous (HET), and PrRP-deficient (KO) mice. DNA was digested with EcoRI 
and hybridized with a 5′ probe. WT allele and targeted allele correspond to the 12.5-kb and 5.5-kb fragments. Southern blot analysis with a 
3′ probe also confirmed that the Prlh locus was properly targeted (data not shown). Quantitative RT-PCR analysis (C) and radioimmunoassay 
(D) confirmed the absence of PrRP transcripts and proteins in the hypothalamus and medulla oblongata of PrRP-deficient mouse. Error bars 
indicate SEM. ir, immunoreactive.
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and no significant differences in oxygen consumption (VO2) dur-
ing 12-hour dark, 12-hour light, and 24-hour periods for mice at 
the ages of 9, 16, and 51 weeks (Figure 4B). The mean respiratory 
exchange ratios were also not significantly different in WT and 
PrRP-deficient mice at the age of 9 (WT, 0.92 ± 0.01, PrRP-defi-
cient, 0.92 ± 0.01), 16 (WT, 0.91 ± 0.01, PrRP-deficient, 0.88 ± 0.01), 
or 51 weeks (WT, 0.81 ± 0.02, PrRP-deficient, 0.84 ± 0.01). In pair-
fed PrRP-deficient mice at the age of 52–54 weeks, neither the total 
VO2 nor the mean respiratory exchange ratios were significantly 
different from those in WT mice (Table 1).
We then examined VO2 in animals whose endogenous PrRP func-
tions were acutely blocked by neutralizing PrRP mAb. We found 
no significant differences between control animals and animals 
pretreated with anti-PrRP mAb (Figure 4C).
Uncoupling proteins are involved in the regulation of ther-
mogenesis and energy expenditure through the sympathetic 
Figure 2
Late-onset obesity in PrRP-deficient mice. (A) Mean BWs of WT, PrRP-heterozygous, and PrRP-deficient mice from heterozygous intercrosses, 
fed a high-fat diet (HF) from the age of 5 weeks. Under the high-fat diet condition, PrRP-deficient mice became heavier than WT and PrRP-
heterozygous mice from the age of 7 weeks (n = 6 or 7). Mean BWs (B) and cumulative food intake (C) of WT and PrRP-deficient mice at the 
ages of 6–72 weeks. PrRP-deficient mice older than 18 weeks were heavier and ate more than WT mice (n = 6). (D) At 66 weeks of age, PrRP-
deficient mice were markedly fatter than WT mice. Scale bar: 5 cm. (E) At the age of 39–40 weeks, PrRP-deficient mice fed standard laboratory 
chow showed reduced glucose tolerance compared with WT mice (n = 5 or 6). (F) Insulin resistance tests at the age of 40–41 weeks showed 
that PrRP-deficient mice also had increased insulin resistance. (Blood glucose concentrations before insulin administration were set as 100%; 
n = 5 or 6.) (G) Mean weight of fat pads of subcutaneous region (Sub), perirenal region (Peri), mesenteric region (Mes), epididymal region (Epi), 
and BAT. At the age of 72 weeks, PrRP-deficient mice had much larger fat masses than WT mice (n = 6). (H) WAT (upper panel) and liver (lower 
panel) of WT and PrRP-deficient mice at the age of 72 weeks (H&E staining). Scale bars: 100 μm. Error bars indicate SEM. †P < 0.05, ‡P < 0.01, 
#P < 0.001 versus WT mice; *P < 0.05 versus PrRP-heterozygous mice.
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nervous system. Therefore, we examined body temperature and 
uncoupling protein 1 (UCP1) mRNA expression in the BAT after 
exposure to cold. There was no significant difference in core body 
temperature between WT and PrRP-deficient mice either before 
(37.5 ± 0.1°C and 37.5 ± 0.1°C, respectively) or after (37.3 ± 0.1 
and 37.2°C ± 0.2°C, respectively) exposure to cold. Expression of 
UCP1 mRNA in the BAT was increased after exposure to cold, but 
with no significant difference between WT and PrRP-deficient 
mice (Figure 4D).
Collectively, these data indicate that the obesity in PrRP-
deficient mice mainly reflects hyperphagia rather than lower 
energy consumption.
Activation of PrRP neurons by food intake. 
We examined the expression of phos-
phorylated cAMP response element–
binding protein (p-CREB) and Fos pro-
tein in PrRP neurons after food intake as 
a marker of neuronal activation. Refeed-
ing following a 24-hour fast increased 
the percentage of p-CREB–positive PrRP 
neurons in the NTS (Figure 5A). The 
number of Fos-positive PrRP neurons 
in the NTS also significantly increased 
after refeeding (Figure 5B). By contrast, there were no significant 
increases in the percentages of p-CREB–positive PrRP neurons either 
in the ventrolateral medulla oblongata (89.6% ± 3.6% [control] and 
90.1% ± 2.1% [refeeding]) or in the dorsomedial hypothalamus fol-
lowing refeeding (3.0% ± 1.5% [control] and 2.4% ± 1.1% [refeeding]). 
The number of Fos-positive PrRP neurons was increased slightly in 
the ventrolateral medulla oblongata (0 ± 0 cells/rat [control] and 
2.8 ± 1.2 cells/rat [refeeding]; P < 0.05) but not in the dorsomedial 
hypothalamus following refeeding (1.0 ± 1.0 cells/rat [control] and 
5.0 ± 2.0 cells/rat [refeeding]).
Food intake after impairment of PrRP signaling. Up to the age of 14 
weeks, the daily food intake of PrRP-deficient mice was not sig-
Figure 3
Energy utilization in PrRP-deficient and WT mice. BW (A) and food intake (B) of mice fed standard laboratory chow (STD) or high-fat diet from the 
age of 12 weeks (at the ages of 10–16 weeks, PrRP-deficient mice fed standard laboratory chow had not yet begun to show obesity). Mice fed 
a high-fat diet gained BW faster, with a significantly greater gain in PrRP-deficient mice. Food intake was greater in PrRP-deficient mice at ages 
when they were heavier than WT mice (n = 4). (C) BWs of WT and pair-fed PrRP-deficient mice from 6 to 57 weeks of age. Half of the mice were 
fed standard laboratory chow or high-fat diet from the age of 12 weeks. The BWs of pair-fed PrRP-deficient mice were not significantly different 
from those of WT mice (n = 6 or 7). (D) At the age of 39–40 weeks, pair-fed PrRP-deficient mice on standard laboratory chow had glucose toler-
ance similar to that of WT mice (n = 6 or 7). (E) At the age of 40–41 weeks, pair-fed PrRP-deficient mice on standard laboratory chow showed 
insulin resistance similar to that of WT mice. (Blood glucose concentrations before insulin administration were set as 100%; n = 6 or 7.) Error 
bars indicate SEM. ‡P < 0.01, #P < 0.001 versus WT mice; *P < 0.05, **P < 0.01, ***P < 0.001 versus mice fed standard chow.
Table 1
VO2 and respiratory exchange ratios in pair-fed PrRP-deficient and WT mice
	 VO2	(ml/kg0.75	per	hour)		 Respiratory	exchange	ratio
	 WT	 PrRP-deficient	 WT	 PrRP-deficient
Standard chow (n = 6 or 7) 1,466 ± 73 1,331 ± 82 0.86 ± 0.02 0.83 ± 0.01
High-fat diet (n = 4) 1,485 ± 118 1,535 ± 58 0.80 ± 0.01 0.78 ± 0.01
Data are expressed as mean ± SEM.
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nificantly different from that of WT mice. However, even at this 
young age when no obesity was evident, PrRP-deficient mice ate 
significantly more after a 24-hour fast than WT mice (Figure 5C), 
suggesting that PrRP is involved in food intake when food intake 
is facilitated by fasting. At the age of 24 weeks, PrRP-deficient mice 
ate more food than WT mice (Figure 5D).
We then examined food intake in rats whose endogenous PrRP 
functions were acutely blocked by neutralizing PrRP mAb. Rats 
pretreated with anti-PrRP mAb ate more during the dark period 
than control rats, whether anti-PrRP mAb was injected immedi-
ately before the dark period or during the light period (Figure 5, 
E and F). Rats injected intracerebroventricularly (i.c.v.) with anti-
PrRP mAb ate more after a 24-hour fast as measured either dur-
ing the dark or the light period (Figure 5, G and H). Thus, immu-
noneutralization of central PrRP facilitates food intake whether 
meal initiation is triggered by the onset of the dark period or by 
fasting. Total daily food intake can be considered as the product 
of meal size and meal frequency. We investigated meal pattern in 
PrRP-deficient mice (Figure 5I) and in rats injected with anti-PrRP 
mAb (Figure 5J). The meal size, but not the meal frequency, was 
higher in PrRP-deficient mice than in WT mice and in rats was 
increased after i.c.v. injection of anti-PrRP mAb.
Figure 4
Energy consumption of PrRP-deficient mice. (A) At the age of 16 weeks, locomotor activity was not significantly different in WT and PrRP-
deficient mice (n = 7). (B) VO2 was not significantly different in WT and PrRP-deficient mice at the age of 9 (n = 9 or 11; right), 16 (n = 9 or 11; 
left, middle, and right), and 51 weeks (n = 5 or 6; right). (C) VO2 was not significantly different in 10- to 11-week-old mice (left) and 12-week-old 
rats (right) that received an i.c.v. injection of anti-PrRP mAb (mice, n = 8; rats, n = 4). (D) Exposure to a cold environment increased UCP1 
mRNA expression in the BAT similarly in WT and PrRP-deficient mice at the age of 24 weeks (n = 4). Error bars indicate SEM. NS, P > 0.05 
versus WT mice.
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PrRP neurons are activated after systemic injections of the 
peripheral satiety signal CCK (11). We therefore measured the 
effects of systemic administration of CCK on food intake in mice 
that had been fasted for 24 hours. CCK had less effect on food 
intake in PrRP-deficient mice than in WT mice (Figure 5K), sug-
gesting that PrRP mediates a satiety signaling of CCK.
To investigate whether PrRP-deficient mice have enhanced fat 
preference, mice were tested on 2-choice macronutrient diet; they 
were given free access to both high-fat and high-carbohydrate diets 
or to both tallow and standard diet. There was no significant dif-
ference between WT and PrRP-deficient mice in the intake ratio of 
high-fat food (Figure 5L) or tallow (Figure 5M), suggesting that 
PrRP-deficient mice had no enhanced preference for fat meals.
Food intake–related peptides in the hypothalamus. We examined the 
expression of appetite-regulating peptides in the hypothalamus 
using in situ hybridization histochemistry. In obese PrRP-defi-
cient mice fed a high-fat diet, the expression of mRNA for the 
anorexigenic peptide corticotrophin-releasing hormone (CRH) 
in the hypothalamic paraventricular nucleus was not different as 
compared with that in WT mice (Table 2). In nonobese PrRP-defi-
Figure 5
Role of endogenous PrRP in food intake. (A and B) Food intake increased the percentage of PrRP neurons expressing p-CREB (A; n = 7 or 9) 
and the number of Fos-positive PrRP neurons (B; n = 7 or 8) in the rat NTS. Photographs show PrRP neurons (brown cytoplasmic reactions) in 
the NTS. A dark nuclear reaction indicates p-CREB immunoreactivity. Scale bar: 30 μm. (C) Food intake after a 24-hour fast in WT and PrRP-
deficient mice at the age of 14 weeks. Food intake was greater in PrRP-deficient mice (n = 9 or 10). (D) Cumulative food intake of WT and 
PrRP-deficient mice at the age of 24 weeks. PrRP-deficient mice ate more food (n = 8). (E–H) Cumulative food intake of rats injected i.c.v. with 
anti-PrRP mAb or mouse IgG at the beginning of the dark period (E and G) or 3 hours after the beginning of the light period (F and H). Rats in 
G and H were fasted before the i.c.v. injection (n = 8 or 9). (I and J) Meal size but not meal frequency was greater in PrRP-deficient mice (14 
weeks old; n = 6 or 10) or rats injected i.c.v. with anti-PrRP mAb (10 weeks old; n = 8) than in control WT mice or control rats. (K) Cumulative food 
intake of WT mice or PrRP-deficient mice injected i.p. with CCK at the age of 19–21 weeks. Suppression of food intake by CCK was blocked in 
PrRP-deficient mice (n = 6 or 7). The intake ratio of high-fat diet (L) or tallow (M) was not significantly different in WT and PrRP-deficient mice at 
the age of 34–37 weeks (n = 4). Error bars indicate SEM. †P < 0.05, ‡P < 0.01, #P < 0.001 versus WT mice; *P < 0.05, ***P < 0.001 versus fasted 
rats, mouse IgG-injected rats, or vehicle-injected mice. HC, high-carbohydrate diet.
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cient mice fed standard laboratory chow at the age of 16 weeks, 
the CRH mRNA expression level was slightly decreased (Table 2), 
but the difference was not statistically significant (P = 0.055). We 
also measured the mRNA expression levels of 2 anorexigenic pep-
tides, proopiomelanocortin (POMC) and cocaine- and amphet-
amine-regulated transcript (CART) and 2 orexigenic peptides, 
agouti-related protein (AgRP) and neuropeptide Y (NPY) in the 
arcuate nucleus and measured orexin mRNA expression in the lat-
eral hypothalamus; there were no significant differences in any of 
these expression levels between PrRP-deficient mice and WT mice 
fed on either standard chow or high-fat diet (Table 2).
Leptin effects on BW and food intake in PrRP-deficient mice. An abnor-
mality in satiety signaling alone does not necessarily cause obesity 
(23), unless it affects fundamental homeostatic mechanisms. As 
leptin is particularly important for long-term metabolic homeo-
stasis, we examined whether leptin administration activates PrRP 
neurons. Leptin induced expression of p-STAT3 in PrRP-expressing 
neurons of the NTS and dorsomedial hypothalamus (Figure 6A). 
We then examined effects of leptin administration in PrRP-deficient 
mice. Peripheral or central administration of leptin reduced food 
intake and BW in WT mice. These effects were much impaired in 
PrRP-deficient mice (Figure 6, B–E), suggesting that PrRP is impor-
tant for relaying leptin signaling to reduce food intake and BW.
Discussion
PrRP is expressed in subpopulations of neurons in the NTS, the 
ventrolateral medulla, and the dorsomedial hypothalamus and has 
been implicated in several physiological processes (24, 25), including 
satiety signaling (10–13, 22), stress-induced release of ACTH and 
oxytocin (16, 19, 26, 27), and nociception (20). In the present study, 
most of the PrRP neurons in the NTS were activated after initiation 
of food intake, with no significant activation of PrRP neurons in the 
hypothalamus. Perturbation of PrRP signaling either by gene KO or 
by administration of neutralizing PrRP mAb increased amounts of 
food intake per meal but not meal frequencies. These data suggest 
that PrRP release from NTS neurons is a central satiety signal.
PrRP-deficient mice showed adult-onset hyperphagia and obe-
sity and exhibited an accompanying impaired glucose tolerance 
and insulin resistance. These data are consistent with reports 
that mice deficient in GPR10, the PrRP receptor, become obese 
in adulthood (15, 21). Although PrRP administration has been 
reported previously to increase energy consumption (13), VO2 
was not significantly changed in PrRP-deficient mice in the 
present study. Neither body temperature changes during 
exposure to a cold environment nor cold exposure–induced 
increase in UCP1 mRNA were different in WT and PrRP-
deficient mice. Locomotor activity was also unchanged in 
PrRP-deficient mice. Furthermore, pair feeding abolished 
the induction of obesity in PrRP-deficient mice. These data 
suggest that PrRP-deficient mice gain more weight than 
WT mice as a result of the increased food intake rather than 
reduced energy expenditure.
In the present study, blocking PrRP signaling in rats by 
administration of anti-PrRP mAb facilitated food intake 
only when food intake was initiated by the onset of the 
dark period or by fasting, suggesting that blocking PrRP 
actions does not itself initiate feeding but instead that feed-
ing continues for longer once initiated. This suggests that 
PrRP might be involved in satiety signaling — a conclusion 
supported by the observation that CCK-induced reduction 
in food intake was impaired in PrRP-deficient mice. These find-
ings are consistent with reports that GPR10-deficient mice have 
impaired responses to CCK (22). As peripheral administration of 
CCK activates most of the PrRP neurons in the medulla oblon-
gata (11), these data suggest that PrRP/GPR10 systems mediate 
the satiety-inducing effects of peripheral CCK. We also found that 
PrRP-deficient mice showed an increase in meal size rather than 
meal frequency, similar to observations in CCKA receptor–defi-
cient mice (23), indicating that CCK/PrRP signaling is important 
for determining meal size.
PrRP is localized in the A2 noradrenergic neurons of the NTS, 
in the A1 noradrenergic neurons of the ventrolateral medulla, 
and in neurons in the dorsomedial hypothalamus (6, 8, 9). Meal 
consumption activates neurons in the NTS (28, 29), including in 
particular noradrenergic neurons (30). In part, this reflects activa-
tion of satiety pathways arising from the gastric vagus, which are 
responsive to CCK. Thus, peripheral administration of CCK acti-
vates noradrenergic neurons in the NTS (5), and these neurons are 
critical for CCK signaling (31, 32). Here we show that food intake 
rapidly activates PrRP neurons in the NTS. The data suggest that 
PrRP neurons in the NTS mediate satiety signaling and support 
the view that satiety circuits are activated coincidentally with food 
intake (30). At present, the precise mechanisms by which PrRP 
reduces food intake remain to be clarified. PrRP may convey sati-
ety signals to the hypothalamus (22), but microinjection of PrRP 
into the dorsal motor nucleus of the vagus also modulates gastric 
motor function (33). It is thus also possible that PrRP may inhibit 
food intake via an action on gastric emptying.
Mice deficient in CCKA receptors do not show obesity (23), 
so the defects in CCKA receptor signaling in PrRP-deficient or 
GPR10-deficient mice might not fully explain the obesity observed 
in PrRP-deficient mice. Leptin administration induces nuclear 
translocation of STAT3 in the dorsomedial hypothalamus (34) 
and p-STAT3 expression in the NTS (35), where PrRP neurons are 
localized. PrRP neurons express leptin receptors (25), and leptin 
administration increases PrRP mRNA (36), suggesting that the 
activity of PrRP neurons is under the control of leptin. Here we 
showed that leptin induces p-STAT3 expression in PrRP neurons, 
especially in the dorsomedial hypothalamus, and that the leptin-
induced reduction in food intake and BW is impaired in PrRP-defi-
cient mice. These data suggest that PrRP neurons, especially those 
in the dorsomedial hypothalamus, might be an important target 
Table 2
Expression of appetite-related peptides in the hypothalamus
	 	 AgRP	 NPY	 Orexin	 CART	 CRH	 POMC
STD
 WT 100 ± 14 100 ± 16 100 ± 2 100 ± 12 100 ± 8 100 ± 7
 KO 79 ± 4 96 ± 211 3 ± 2 126 ± 8 70 ± 2 95 ± 5
HF
 WT 98 ± 9 89 ± 9 109 ± 9 108 ± 11 87 ± 9 78 ± 7
 KO 93 ± 29 8 ± 11 105 ± 7 136 ± 14 82 ± 5 94 ± 5
Values are expressed as the mean percentage of probe binding as compared 
with that in WT mice fed standard chow. Mean levels of mRNAs (±SEM) for 
AgRP, NPY, CART, and POMC in the arcuate; orexin in the lateral hypothala-
mus; and CRH in the paraventricular nucleus in mice at the age of 16 weeks 
given free access to standard chow or high-fat diet for 4 weeks. There were no 
significant differences between WT mice and PrRP-deficient (KO) mice (n = 4). 
STD, standard chow; HF, high-fat diet.
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of leptin’s actions to restrain food intake or that leptin modulates 
the effects of PrRP by its actions on the neuronal targets of PrRP.
GPR10-deficient mice show reduced energy expenditure (15), 
and as acute administration of PrRP increases VO2 (13), these data 
suggest that PrRP plays a role in energy expenditure. However, in 
the present study, VO2 was not different in WT and PrRP-deficient 
mice, and acute blockade of PrRP signaling by anti-PrRP mAb did 
not increase VO2. Furthermore, the obesity observed in PrRP-
deficient mice could be fully reversed by pair feeding. These data 
suggest that endogenous PrRP does not play an important role in 
energy expenditure in basal conditions. The apparent discrepan-
cies concerning energy expenditure between GPR10-deficient and 
PrRP-deficient mice remain to be clarified.
Energy homeostasis is regulated by various orexigenic and 
anorexigenic peptides in the hypothalamus. Administration of 
PrRP activates CRH neurons in the hypothalamus (37), and 
PrRP-induced anorexia is attenuated by a CRH receptor antag-
onist (13). However, in the present study, there was no signifi-
cant decrease in CRH mRNA expression in the paraventricular 
nucleus, suggesting that changes in CRH neuronal activity 
may not be the main cause of obesity in PrRP-deficient mice. 
We also found that the expression levels of mRNAs encoding 
appetite-regulating peptides, AgRP, NPY, orexin, CART, and 
POMC, were normal in PrRP-deficient mice, indicating that 
the hyperphagia observed in PrRP-deficient mice is unlikely to 
be the result of a grossly perturbed functioning of these hypo-
thalamic neuronal populations.
Both PrRP-deficient mice and GPR10-deficient mice show 
adult-onset obesity (15, 21), but there are several differences. 
Hyperphagia is not obvious in GPR10-deficient mice (22) but is 
clear in PrRP-deficient mice, and a high-fat diet can induce obe-
sity in PrRP-deficient but not in GPR10-deficient mice (21). It is 
possible that PrRP acts on not only GPR10 but also other recep-
tors, including neuropeptide FF receptor 2 (38). Administration 
of PrRP reduces food intake in rats with a naturally occurring 
polymorphism of the Prlhr gene that abolishes its ability to bind 
PrRP (39), suggesting that receptors other than GPR10 also play 
a role in the action of PrRP on feeding behavior. It is also possi-
ble that ligands other than PrRP might exist for GPR10. In con-
clusion, this study indicates that PrRP is a potent satiety peptide 
in the rodent CNS that contributes to the determination of meal 
size and that perturbation of PrRP signaling can predispose to 
obesity, mainly due to hyperphagia.
Methods
Generation of PrRP-deficient mice. To construct the targeting vector, a Prlh 
genomic clone was isolated from a 129/Svj-derived RW-4 ES cell genomic 
library. The Prlh gene targeting vector was designed to replace a 2.0-kb 
BamHI-HpaI fragment including exons 1 and 2 constituting the entire 
coding region, with a neomycin phosphotransferase resistance cassette 
(neo). A 2.1-kb VspI-BamHI fragment was used as the 5′ homology region 
and a 5.0-kb HpaI-EcoRI fragment was used as the 3′ homology region. 
We linearized the targeting vector and electroporated it into RW-4 ES cells 
(Genome Systems Inc.). We selected G418-resistant clones and screened 
them by Southern blot analysis. Heterozygous ES cell clones were injected 
into blastocysts of C57BL/6N mice (Charles River Laboratories) and trans-
Figure 6
Changes in BW and food intake after leptin administration. (A) 
Expression of p-STAT3 in PrRP neurons following i.c.v. injec-
tion of leptin in C57BL/6N mice (11 weeks old). Leptin increased 
the percentage of PrRP neurons expressing p-STAT3 in the NTS 
and dorsomedial hypothalamus (DMH) but not in the ventrolateral 
medulla oblongata (VLM) (n = 4). Photographs show PrRP neurons 
(brown cytoplasmic reactions) in the DMH. A dark nuclear reaction 
indicates p-STAT3 immunoreactivity. Scale bar: 30 μm. BW (B) and 
food intake (C) of WT or PrRP-deficient mice injected i.p. with leptin 
at the age of 16 weeks. The effects of leptin on BW and food intake 
were attenuated in PrRP-deficient mice (n = 7). BW (D) and food 
intake (E) of WT or PrRP-deficient mice injected i.c.v. with leptin 
at the age of 18–19 weeks. The effects of i.c.v. leptin on BW and 
food intake were attenuated in PrRP-deficient mice (n = 9–20). Error 
bars indicate SEM. †P < 0.05, ‡P < 0.01 versus WT mice; *P < 0.05, 
**P < 0.01 versus vehicle-injected mice.
research article
4022	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 118   Number 12   December 2008
ferred into uteri of pseudopregnant females. Chimeric males were mated to 
C57BL/6N females, and the resulting heterozygous mice were intercrossed. 
Their offspring were screened by Southern blot analysis. PrRP-deficient 
mice backcrossed into C57BL/6N background for 8 generations were used 
in this study. Permission of Takeda Chemical Industries Ltd. is necessary 
for the distribution of PrRP-deficient mice.
Animals. Animals were housed in a temperature- (22 ± 2°C) and humid-
ity-controlled (40%–70%) room with a 12-hour light/12-hour dark cycle 
(light on 7:30–19:30). Food and water were available ad libitum. All animal 
procedures were approved by the Judging Committee of Experimental Ani-
mal Ethics of Jichi Medical University and were in accordance with Japa-
nese legislation concerning animal experiments.
Intraperitoneal glucose tolerance test and insulin tolerance test. For the glucose 
tolerance test, male WT and PrRP-deficient mice (39–40 weeks old) were 
fasted for 14 hours (23:00–13:00) and injected i.p. with glucose (2 g/kg 
BW). For the insulin tolerance test, male mice (40–41 weeks old) were 
fasted for 4 hours (9:00–13:00) and then injected i.p. with insulin (1 U/kg 
BW; Novolin; Novo Nordisk). For both tests, blood samples were taken 
from the tail vein at 0, 15, 30, 60, and 120 minutes after loading. Blood 
glucose concentrations were determined by an enzymatic method using a 
GLUCOCARD DIA meter (ARKRAY).
High-fat diet. Male WT mice or PrRP-deficient mice were given either 
standard laboratory chow (CE-2; CLEA Japan) or a high-fat diet (Quick 
Fat; CLEA Japan) from the age of 5 weeks or for 4 weeks from the age of 
12 weeks. The standard laboratory chow contains 12% fat, 29% protein, 
and 59% carbohydrates, with a caloric density of 3.45 kcal/g. The high-
fat diet has 31% fat, 24% protein, and 45% carbohydrates, with a caloric 
density of 4.11 kcal/g.
Pair feeding. Male WT and PrRP-deficient mice were housed individually 
from 6 weeks of age, provided with food ad libitum, and weighed weekly. 
Pair feeding of standard laboratory chow or high-fat diet was started at 
the age of 12 weeks.
Surgery and i.c.v. injection of an anti-PrRP mAb. Male animals were anesthe-
tized with Avertin (200 mg/kg BW, i.p.; tribromoethanol; Sigma-Aldrich) 
and placed in a stereotaxic frame. Stainless steel guide cannulae (25-gauge 
[mice] or 23-gauge [rats]) were inserted into the right lateral cerebral ven-
tricle (mice: 0.4 mm caudal to bregma, 1.0 mm lateral to the midline, and 
2.0 mm below the skull; rats: 0.6 mm caudal to bregma, 1.6 mm lateral to 
the midline, and 4.5 mm below the skull) and secured to the skull with 
screws and dental cement. The position of the tip was verified with methy-
lene blue injected through the cannulae after experiments. Animals were 
allowed to recover for 1 week. Animals were injected i.c.v. with anti-PrRP 
mAb (2 μl [mice] or 8 μl [rats]; 4.9 mg/ml P2L-1C; Takeda Pharmaceutical 
Co.) (8, 19, 26, 37) or control IgG (4.9 mg/ml mouse IgG; Sigma-Aldrich) 
via inner cannulae (32-gauge [mice] or 30-gauge [rats]). Permission of 
Takeda Chemical Industries Ltd. is necessary for the distribution of anti-
PrRP mAb (P2L-1C).
Locomotor activity and VO2. Spontaneous motor activity was recorded 
in the home cage by the activity sensor unit (O’hara and Co.) (40). VO2 
and carbon dioxide production (VCO2) were measured simultaneously 
for 4 animals using an indirect calorimeter (Oxymax Equal Flow System; 
Columbus Instruments) with an airflow of 0.8 l/min (mice) or 2 l/min 
(rats). Animals were placed in individual calorimeter chambers. After a 
2-hour acclimation period, VO2 (ml/kg BW0.75 per hour) was measured 
every 5 minutes for 24 hours. In the experiments with WT and PrRP-defi-
cient mice, the measurements were conducted in male mice with free access 
to food (9, 16, and 51 weeks old) or under pair-fed conditions (52–54 weeks 
old). In the experiments with an i.c.v. injection, anti-PrRP mAb or mouse 
IgG was injected i.c.v. into male mice (10–11 weeks old; C57BL/6N; Charles 
River Laboratories) or male rats (12 weeks old, std:Wistar; SLC Japan) after 
a 1-hour baseline measurement of VO2, and the measurements were con-
ducted in animals with no access to food. The VO2 values from 12 consecu-
tive readings, encompassing a 1-hour period, were averaged for analysis. 
The respiratory exchange ratio was calculated as VCO2/VO2.
Exposure to a cold environment. Male WT or PrRP-deficient mice (24 weeks 
old) were placed in an incubator at 2°C for 6 hours. Body temperature 
was measured with a rectal temperature probe (model BDT-100; BRC). 
For measurements of Ucp1 mRNA, mice were deeply anesthetized i.p. 
with pentobarbital (50 mg/kg BW; Nembutal; Dainippon Pharmaceu-
tical) 24 hours after the cold exposure, and the BAT was obtained. The 
total RNA of the BAT was isolated using TRIzol (Invitrogen) and treated 
with RQ1-DNase (Promega) to remove residual contamination with DNA. 
First-strand cDNA synthesis was completed using ReverTra Ace (Toyo-
bo). Primers for quantitative RT-PCR were first examined by HotStarTaq 
DNA polymerase (94°C for 15 seconds, 60°C for 20 seconds, and 72°C for 
20 seconds × 30 cycles; QIAGEN) and agarose gel electrophoresis for cor-
rect product size and absence of primer-dimer formation. Using a Quan-
tiTect SYBR Green PCR kit (QIAGEN), quantitative RT-PCRs (95°C for 
15 seconds, 60°C for 20 seconds, and 72°C for 20 seconds × 40 cycles) 
were performed in an ABI-Prism 7700 sequence detector (Applied Biosys-
tems). Product accumulation was measured in real time, and the mean 
Ct was determined for replicate samples on the same plate. Different 
cDNA samples were normalized using primer sets to Gapdh. Primers for 
Gapdh were 5′-GGCACAGTCAAGGCTGAGAATG-3′ and 5′-ATGGTGGT-
GAAGACGCCAGTA-3′; those for Ucp1 were 5′-CGACAACTTCCGAAGT-
GCAAC-3′ and 5′-TGGATCTGAAGGCGGACTTT-3′.
Detection of activated PrRP neurons after food intake. To detect p-CREB 
in PrRP neurons, male rats (9 weeks old, std:Wistar; SLC Japan) were 
anesthetized with Avertin, and polyethylene catheters (PE50; BD) were 
inserted into the right jugular vein. Seven days later, the rats were fasted 
for 24 hours (19:30–19:30). One group of rats was refed for 30 minutes 
after the fast, anesthetized with pentobarbital (60 mg/kg BW, i.v.), and 
perfused transcardially with heparinized saline (20 U/ml), followed by 
3.75% acrolein and 2% PFA in 0.1 M phosphate buffer (pH 7.4). The brains 
were removed, postfixed in 3.75% acrolein and 2% PFA overnight, and 
transferred to 30% sucrose solution in 0.1 M phosphate buffer until tis-
sue sank. The brains were frozen on dry ice and stored at –80°C. Coronal 
sections were cut at 30 μm with a freezing sledge microtome. Every fourth 
section of the hypothalamus and the medulla oblongata was collected 
and processed for immunohistochemistry. Sections were pretreated with 
0.5% sodium metaperiodate for 20 minutes and with 1% sodium borohy-
dride for 20 minutes. The sections were incubated for 15 minutes with 
1.5% H2O2 solution to block endogenous peroxidase, with 10% normal 
goat serum for 1 hour, and then with a rabbit polyclonal Ab against 
p-CREB (diluted 1:200; Ser133; Cell Signaling Technology) for 48 hours 
at 4°C, followed by incubation with biotinylated goat anti-rabbit IgG 
(2 μg/ml BA-1000; Vector Laboratories) for 2 hours and then with avidin-
biotinylated horseradish peroxidase complex (VECTASTAIN Elite ABC 
Kit; Vector Laboratories) for 30 minutes at room temperature. p-CREB 
immunoreactivity was visualized as a black nuclear precipitate using a 
glucose oxidase–based, nickel-intensified, 3,3′-diaminobenzidine pro-
cedure. p-CREB immunolabeled sections were treated with 1.5% H2O2 
and 10% normal horse serum and then incubated with a mouse anti-
PrRP mAb (5 μg/ml P2L-1T; Takeda Pharmaceutical Co.) for 48 hours at 
4°C (6), followed by incubation with biotinylated horse anti-mouse IgG 
(1 μg/ml BA-2001; Vector Laboratories) and then with avidin-biotinylated 
horseradish peroxidase complex for 30 minutes at room temperature. 
PrRP immunoreactivity was visualized as a brown cytoplasmic precipitate 
using a 3,3′-diaminobenzidine procedure. For detection of Fos protein in 
PrRP neurons, male rats (9 weeks old, std:Wistar; SLC Japan) were fasted 
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for 24 hours (10:00–10:00). One group of rats was refed for 2 hours after 
the fast, anesthetized i.p. with pentobarbital, and perfused with acrolein 
and PFA. Coronal brain sections were cut at 30 μm with a freezing sledge 
microtome. Every fourth section of the hypothalamus and the medulla 
oblongata was collected and processed for immunohistochemistry. Fol-
lowing treatments with sodium metaperiodate, sodium borohydride, and 
H2O2, the sections were incubated with 10% normal goat serum and incu-
bated with a rabbit polyclonal Ab against Fos protein (diluted 1:10,000; 
Oncogene) for 48 hours at 4°C. The sections were incubated overnight 
with peroxidase-labeled goat anti-rabbit IgG (1 μg/ml PI-1000; Vector 
Laboratories) at 4°C. Fos immunoreactivity was visualized as a black 
nuclear precipitate using a glucose oxidase–based, nickel-intensified, 
3,3′-diaminobenzidine procedure. Fos-immunolabeled sections were 
treated for detection of PrRP immunoreactivity, as described above. The 
number of PrRP-positive cells that were positive or negative for p-CREB 
or Fos protein was determined, and the percentage of PrRP-positive cells 
expressing p-CREB was calculated for each rat. Fourteen sections of the 
caudal brainstem (between –1,560 μm and 0 μm relative to the obex) 
were examined in each rat. For the dorsomedial hypothalamus, cells were 
counted in 3 sections per rat at a 120-μm interval to give a mean value for 
each rat; these values were averaged to determine a group mean. Permis-
sion of Takeda Chemical Industries, Ltd. is necessary for the distribution 
of anti-PrRP mAb (P2L-1T).
Measurements of food intake after i.c.v. injection of an anti-PrRP mAb. Seven 
days after cannula implantation, male rats (10 weeks old, std:Wistar; SLC 
Japan) were injected i.c.v. with anti-PrRP mAb or control IgG, and cumula-
tive food intake was measured by an automatic food counter (O’hara and 
Co.). An i.c.v. injection was performed at the beginning of the dark period 
or 3 hours after the onset of the light period. Half of the rats were fasted 
for 24 hours until the i.c.v. administration.
Measurements of meal size and meal frequency. Food intake was recorded 
every minutes by an automatic food counter (O’hara and Co.). For male 
WT and PrRP-deficient mice (14 weeks old), meal initiation was defined 
as more than 50 mg pellets within 10 minutes. Once a meal was initiated, 
meal termination was defined as the onset of a 10-minute interval with no 
intake. For male rats (10 weeks old, std:Wistar; SLC Japan), meal initiation 
was defined as a minimum of 100 mg pellets within 10 minutes.
Administration of CCK. Male WT and PrRP-deficient mice (19–21 weeks 
old) were individually housed, deprived of food for 24 hours, and injected 
i.p. at 11:00 with saline or CCK-octapeptide26–33 (sulfated form) (20 μg/
kg BW; Peptide Institute). Cumulative food intake was measured before 
and after injection.
Two-choice macronutrient diet test. Male WT and PrRP-deficient mice at the 
age of 34–37 weeks had free access to both high-fat diet (Quick Fat) and 
high-carbohydrate diet (63.7% of calories from carbohydrate and 9.6% of 
calories from fat, 360.7 kcal/100 g; KBT Oriental Co.). Daily food intake 
was measured for 9 days. Other mice had free access to both standard labo-
ratory chow (CE-2) and tallow. The daily calories from the high-fat diet or 
tallow were calculated as a ratio of total caloric intake and averaged for 
the last 2 days.
In situ hybridization. The brains of mice fed either standard laboratory 
chow or a high-fat diet for 4 weeks from the age of 12 weeks were ana-
lyzed for mRNA levels of food intake–related peptides. Semiquantitative 
in situ hybridization was performed using antisense probes for AgRP, 
NPY, orexin, CART, CRH, and POMC mRNAs as described in detail pre-
viously (41–43). We analyzed the images in an MCID imaging analyzer 
(Imaging Research Inc.).
Leptin injection and detection of activated PrRP neurons after leptin injection. 
Murine recombinant leptin (Peprotech) was dissolved in 5 mM sodium 
citrate buffer (pH 4) and stored at –80°C. Immediately before use, the pH 
of the solution was adjusted to 7.0–7.5 by addition of sodium hydroxide. 
For measurement of BWs and food intake, male WT and PrRP-deficient 
mice (i.p., 16 weeks old; i.c.v., 18–19 weeks old) were housed individually 
and injected i.p. at 8:00 and at 18:00 or i.c.v. at 11:00 with vehicle (mix-
ture solution of sodium citrate, pH 4, and 0.01 M sodium hydroxide; final 
pH, 7.2) or leptin (i.p., 2.5 mg/kg BW; i.c.v., 0.2 μg/2 μl/mouse) for 3 days. 
For detection of PrRP neurons activated after leptin injection, male mice 
(11 weeks old, C57BL/6N mice (Charles River Laboratories) were injected 
i.c.v. with leptin (5 μg/2 μl/mouse) and perfused with acrolein and PFA. 
Coronal brain sections were cut at 30 μm with a freezing sledge microtome. 
Every second section of the hypothalamus and the medulla oblongata was 
collected and processed for immunohistochemistry. After treatments 
with sodium metaperiodate, sodium borohydride, and H2O2, the sections 
were blocked in M.O.M Mouse Ig Blocking Reagent (Vector Laboratories), 
incubated with normal goat serum and then with normal goat serum and 
P2L-1T for 48 hours at 4°C, followed by treatment with a peroxidase-
labeled polymer conjugated to goat anti-mouse immunoglobulins 
(EnVision+ system; Dako) for 2 hours at room temperature. PrRP immu-
noreactivity was visualized as a brown cytoplasmic precipitate using a 
3,3′-diaminobenzidine procedure. PrRP-immunolabeled sections were 
treated with H2O2 and normal goat serum and then incubated with a rab-
bit mAb against p-STAT3 (diluted 1:100; Tyr705; Cell Signaling Technol-
ogy) for 48 hours at 4°C, followed by treatment with a peroxidase-labeled 
polymer conjugated to goat anti-rabbit immunoglobulins (EnVision+ sys-
tem; Dako) for 2 hours at room temperature. p-STAT3 immunoreactivity 
was visualized as a black nuclear precipitate using a glucose oxidase–based, 
nickel-intensified, 3,3′-diaminobenzidine procedure. The number of PrRP-
positive cells that were positive or negative for p-STAT3 was determined, 
and the percentage of PrRP-positive cells expressing p-STAT3 was calcu-
lated for each mouse. Twenty sections of the caudal brainstem (between 
–1,140 μm and 0 μm relative to the obex) were examined in each mouse. 
For the dorsomedial hypothalamus, cells were counted in 11 sections per 
mouse (60-μm intervals) to give a mean value for each mouse; these values 
were averaged to determine a group mean.
Statistics. Changes in food intake, BW, blood glucose concentrations, 
motor activity, and VO2 were analyzed by repeated-measures ANOVA. 
Other data were analyzed by 1-way ANOVA followed by Scheffé’s multiple 
comparison test or 2-tailed t test. A P value of less than 0.05 was considered 
statistically significant.
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